MGAT2 inhibitors divulged in Evopoint Biosciences patent

FierceBiotechSanofi CFO defends Hudson’s Dupixent legacy, but accepts ‘number of setbacks’ in R&D

FierceBiotechFrom debt to ‘acceptable’ prices: Roche CEO lists 3 reasons for sitting out Big Pharma M&A spree

Thermo FisherThermo Fisher Scientific (NYSE:TMO) Beats Q1 Estimates But Stock Drops in Pre-Market - ChartMill

10x Genomics BlogLiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor - Yahoo Finance Singapore

Thermo FisherThermo Fisher posts quarterly results beat as lab products, biopharma services grow - Reuters

Thermo FisherTHERMO FISHER SCIENTIFIC ($TMO) Releases Q1 2026 Earnings - Quiver Quantitative

AgilentUniversal Beteiligungs und Servicegesellschaft mbH Sells 54,276 Shares of Agilent Technologies, Inc. $A - MarketBeat

Thermo Fisher[8-K] THERMO FISHER SCIENTIFIC INC. Reports Material Event - Stock Titan

Thermo FisherThermo Fisher Scientific Reports First Quarter 2026 Results - Yahoo Finance

AgilentBoston Trust Walden Corp Sells 21,880 Shares of Agilent Technologies, Inc. $A - MarketBeat

Thermo FisherTMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Borrow Rate - Xã Thanh Hà

AgilentIs Agilent Technologies a Better Buy Than Danaher? - Trefis